No-shows at hearing on Medicare costs stir fury
SEATTLE POST-INTELLIGENCER
http://seattlepi.nwsource.com/national/167448_medicare02.html
No-shows at hearing on Medicare costs stir fury
Key figures in debate over prescription drugs snub House
Friday, April 2, 2004
By SHERYL GAY STOLBERG
THE NEW YORK TIMES
WASHINGTON -- A senior White House official and the former Medicare administrator, central figures in a controversy over the cost of the new prescription drug law, declined to appear before a House committee yesterday, defying Democrats who had sought their testimony.
Citing executive privilege, the White House refused to send Doug Badger, the special assistant to the president for health policy, to testify before the House Ways and Means Committee. The former Medicare administrator, Thomas Scully, who no longer works for the government, wrote the committee a letter saying he had been busy traveling and would be unable to appear.
Democrats then tried to persuade the committee to subpoena them, but those motions failed along party lines, by votes of 23-16. When Rep. Lloyd Doggett, D-Texas, suggested that the panel invite Scully to appear on a more convenient date, the committee's chairman, Rep. Bill Thomas of California, dismissed the idea.
"The chair's reading of Mr. Scully's letter is, he ain't coming," Thomas declared.
The development infuriated Democrats, who are trying to investigate accusations by the chief Medicare actuary, Richard Foster, that Scully, as administrator, threatened to fire him if he shared his prescription-cost estimates with Congress last year, before the legislation was enacted. Foster has suggested that Scully was acting on orders from the White House, possibly from Badger.
Doggett called Badger "the Condoleezza Rice for health care." In refusing to send Badger, the administration invoked the same principle it had cited until Tuesday in refusing to send Rice to testify before the Sept. 11 commission: a "longstanding White House policy," in the words of Alberto Gonzales, the White House counsel, that aides who are exempt from Senate confirmation are also exempt from being required to testify before Congress, so that they may feel free to give the president unfettered advice.
Gonzales cited this principle in a letter to the Ways and Means Committee on Wednesday in which he said that on behalf of Badger, he would "respectfully decline the invitation."
As for Scully, he wrote the panel a two-page letter in which he said he dealt with Foster "openly and fairly during my entire tenure." He did not address the accusation that he had threatened to fire Foster, but he did say that when he was administrator, Foster was not free to communicate directly with lawmakers.
"There is no question whatsoever," he wrote, "that I made it very clear to Foster, both directly and indirectly, that I, as his supervisor, would decide when he would communicate with Congress."
Foster's figures are important because he calculated that the cost of the prescription drug bill would far exceed the $400 billion estimated by Congress. Had his calculations been widely known at the time the bill was considered last year, the measure might have failed, or been significantly altered.